Combined acylated catalpol diglycoside and Lactobacillus therapy restores the miR-146a–TRAF6–SIRT1/AMPK signaling axis in experimental colitis

Ahmed M. El-Baz, Reham M. Goda, Hany N. Baraka, Ahmed S. Saad, Ahmed E. Amer, Amir Mohamed Abdelhamid, Mohamed M. Salama, Hala M. Anwer, Shaymaa Ali, Azza M. Marei, Attalla F. El-kott, Sally Negm, Mohammed A. AlShehri, Amal M.H. Ghanim, Shaimaa A. Ashmawy, Moustafa M. Saleh, Sameh Saber

Open source

DOI: 10.1016/j.taap.2026.117874
Published: 2026-08
Container: Toxicology and Applied Pharmacology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.taap.2026.117874,
  title = {Combined acylated catalpol diglycoside and Lactobacillus therapy restores the miR-146a–TRAF6–SIRT1/AMPK signaling axis in experimental colitis},
  author = {Ahmed M. El-Baz and Reham M. Goda and Hany N. Baraka and Ahmed S. Saad and Ahmed E. Amer and Amir Mohamed Abdelhamid and Mohamed M. Salama and Hala M. Anwer and Shaymaa Ali and Azza M. Marei and Attalla F. El-kott and Sally Negm and Mohammed A. AlShehri and Amal M.H. Ghanim and Shaimaa A. Ashmawy and Moustafa M. Saleh and Sameh Saber},
  year = {2026},
  journal = {Toxicology and Applied Pharmacology},
  doi = {10.1016/j.taap.2026.117874},
  url = {https://doi.org/10.1016/j.taap.2026.117874}
}

RIS

TY  - JOUR
TI  - Combined acylated catalpol diglycoside and Lactobacillus therapy restores the miR-146a–TRAF6–SIRT1/AMPK signaling axis in experimental colitis
AU  - Ahmed M. El-Baz
AU  - Reham M. Goda
AU  - Hany N. Baraka
AU  - Ahmed S. Saad
AU  - Ahmed E. Amer
AU  - Amir Mohamed Abdelhamid
AU  - Mohamed M. Salama
AU  - Hala M. Anwer
AU  - Shaymaa Ali
AU  - Azza M. Marei
AU  - Attalla F. El-kott
AU  - Sally Negm
AU  - Mohammed A. AlShehri
AU  - Amal M.H. Ghanim
AU  - Shaimaa A. Ashmawy
AU  - Moustafa M. Saleh
AU  - Sameh Saber
PY  - 2026
JO  - Toxicology and Applied Pharmacology
DO  - 10.1016/j.taap.2026.117874
UR  - https://doi.org/10.1016/j.taap.2026.117874
ER  -

APA

El-Baz, A. M., Goda, R. M., Baraka, H. N., Saad, A. S., Amer, A. E., Abdelhamid, A. M., Salama, M. M., Anwer, H. M., Ali, S., Marei, A. M., El-kott, A. F., Negm, S., AlShehri, M. A., Ghanim, A. M., Ashmawy, S. A., Saleh, M. M., & Saber, S. (2026). Combined acylated catalpol diglycoside and Lactobacillus therapy restores the miR-146a–TRAF6–SIRT1/AMPK signaling axis in experimental colitis. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2026.117874

Source records

crossref · retrieved 2026-09-27T09:53:14.400Z